| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/14/2004 | CN1467289A Method for extracting microorganism producing biological active substance from sponge cell |
| 01/14/2004 | CN1467248A Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers |
| 01/14/2004 | CN1134541C Use of tomato E8-derived promoters to express heterologous genes, E.G. 5-adenosylmethionine hydrolase, in ripening fruit |
| 01/14/2004 | CN1134539C Thrombopoietin |
| 01/14/2004 | CN1134537C Preparation of human primitive mesenchymal stem cell population |
| 01/14/2004 | CN1134452C Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 01/13/2004 | US6677508 Hybrid maize plant and seed 39A46 |
| 01/13/2004 | US6677505 Promoter inductible in plants, sequence incorporating same and resulting product |
| 01/13/2004 | US6677502 Plant metabolism genes |
| 01/13/2004 | US6677501 P2X7 receptor-deficient mice and uses thereof |
| 01/13/2004 | US6677443 Isolated nucleic acid encoding lepidopteran octopamine/ tyramine transporter having sodium-dependent transport activity which has affinity for dopamine and which is inhibited by octopamine and tyramine |
| 01/13/2004 | US6677442 Isolated nucleic acid molecule comprising nucleotide sequence encoding polypeptide having specified amino acid sequence |
| 01/13/2004 | US6677434 Isolated mammalian nucleic acid molecule encoding a receptor protein tyrosine kinase expressed in primitive hematopcietic cells and not expressed in mature hematopoietic cells |
| 01/13/2004 | US6677301 Epithelial cell proliferation stimulants; wound healing agents |
| 01/13/2004 | US6677299 Method to increase cerebral blood flow in amyloid angiopathy |
| 01/13/2004 | US6677157 Method of diagnosis of prostate cancer |
| 01/13/2004 | US6677156 Non-adenoviral gene product-based complementing cells for adenoviral vectors |
| 01/13/2004 | US6677155 Triple hybrid amplicon vector systems to generate retroviral packaging lines |
| 01/13/2004 | US6677154 Prepartion of growth nutrient for plants; obtain plant, remove stems, propagate in tissue culture |
| 01/13/2004 | US6677148 Pesticidal proteins |
| 01/13/2004 | US6677145 Isolating a nucleotide sequence having specific sequence, constructing a vector consists of an isolated nucleotide sequence operably linked to a promoter, introducing the vector into host cell for expression of elongase enzyme |
| 01/13/2004 | US6677138 Production of a multimeric protein by cell fusion method |
| 01/13/2004 | US6677126 Antibody for human translational regulator |
| 01/13/2004 | US6677124 Monoclonal antibody recognizing C-terminus of hBNP |
| 01/13/2004 | US6676985 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
| 01/13/2004 | US6676969 Purified collagen ii derived from natural cartilage tissue from which non-collagen proteins have been removed. |
| 01/13/2004 | US6676941 For inhibiting angiogenesis and induce tumor regression; cancer therapy |
| 01/13/2004 | US6676939 Methods of modulating IL-174 response |
| 01/13/2004 | US6676938 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 01/13/2004 | US6676937 Compositions and methods for modulating vascularization |
| 01/13/2004 | US6676924 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
| 01/13/2004 | US6676675 Patterned substrates and methods for nerve regeneration |
| 01/13/2004 | CA2112811C Continuous cell line and vaccine against avian coccidia |
| 01/08/2004 | WO2004003511A2 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 01/08/2004 | WO2004003218A2 Antisense modulation of hypothetical protein loc51249 expression |
| 01/08/2004 | WO2004003209A2 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 01/08/2004 | WO2004003207A1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 01/08/2004 | WO2004003206A1 Novel transglucuronidases and genes tehreof |
| 01/08/2004 | WO2004003202A1 Modified par receptors, their preparation and their uses for selecting compounds which modulate par activity |
| 01/08/2004 | WO2004003196A1 HUMAN IgM ANTIBODY LYSING ACTIVATED LYMPHOCYTES UNDER MEDIATION BY HOMOLOGOUS COMPLEMENT |
| 01/08/2004 | WO2004003186A2 Subtilases and subtilase variants having altered immunogenicity |
| 01/08/2004 | WO2004003185A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 01/08/2004 | WO2004003183A1 Immunoliposome conjugated with anti-upa antibody |
| 01/08/2004 | WO2004003182A2 Homozygous stem cells isolated from pathogenic oocytes |
| 01/08/2004 | WO2004003181A2 Method for preparing animal or human adult stem cells and therapeutic use thereof |
| 01/08/2004 | WO2004003179A1 Differentiation modulating agents and uses therefor |
| 01/08/2004 | WO2004003178A2 Decellularized tissue |
| 01/08/2004 | WO2004003176A2 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 01/08/2004 | WO2004003166A2 Antibodies and uses thereof |
| 01/08/2004 | WO2004003164A2 Methods of organ regeneration |
| 01/08/2004 | WO2004003157A2 Gene regulation in transgenic animals using a transposon-based vector |
| 01/08/2004 | WO2004003151A2 Protein production methods and modified cells for use therein |
| 01/08/2004 | WO2004003142A2 Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
| 01/08/2004 | WO2004003137A2 Method for suppression or reversing of cellular aging |
| 01/08/2004 | WO2004003130A1 Chitosan/acidic biopolymer hybrid fiber and culture base for animal cells |
| 01/08/2004 | WO2004002459A1 Hollow nanoparticle having modified cysteine residue and drug with the use thereof |
| 01/08/2004 | WO2004002431A2 Humanized anti-lymphotoyin beta receptor antibodies |
| 01/08/2004 | WO2004002428A2 Derivatives of gambogic acid and induce apoptosis |
| 01/08/2004 | WO2004002424A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2004002223A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/08/2004 | WO2003093455A3 Adenovirus vectors for immunotherapy |
| 01/08/2004 | WO2003085092A3 Cellular transplantation for heart regeneration |
| 01/08/2004 | WO2003083044A3 Tissue analogs for in vitro testing and method of use therefor |
| 01/08/2004 | WO2003080815A3 Method for activating dendritic cells |
| 01/08/2004 | WO2003078614A3 Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants |
| 01/08/2004 | WO2003070875A3 Container with at least one electrode |
| 01/08/2004 | WO2003069972A3 Hepatocyte precursor cell lines |
| 01/08/2004 | WO2003068149A3 Preparations of nucleus pulposus cells and methods for their generation, identification, and use |
| 01/08/2004 | WO2003063766A3 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 01/08/2004 | WO2003054552A3 Automated system and method for processing specimens to extract samples for both liquid-based and slide-based testing |
| 01/08/2004 | WO2003050238A3 Receptor-targeted adenoviral vectors |
| 01/08/2004 | WO2003039382A3 System for processing tissue |
| 01/08/2004 | WO2003033687A3 Lift-off process for a hard etch mask for magnetic memory cells in mram devices |
| 01/08/2004 | WO2003031570A3 METHOD FOR CLONING AND EXPRESSION OF BseRI RESTRICTION ENDONUCLEASE AND BseRI METHYLASE IN E. COLI |
| 01/08/2004 | WO2003025169A3 Nucleic acid for cloning vector |
| 01/08/2004 | WO2003020876A3 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 01/08/2004 | WO2003020257A3 USE OF β-ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| 01/08/2004 | WO2003007890A3 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor |
| 01/08/2004 | WO2003007800A3 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/08/2004 | WO2003004658A3 Gene expression in plastids based on replicating vectors |
| 01/08/2004 | WO2003000859A3 G-protein coupled receptors |
| 01/08/2004 | WO2002103016B1 Human tachykinin-related splice variants and compositions thereof |
| 01/08/2004 | WO2002099036A3 Inhibition of neurodegeneration |
| 01/08/2004 | WO2002095067A3 INTERFERON α-14 POLYMORPHISM |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |
| 01/08/2004 | WO2002072796A3 Continuous, normal human t-lymphocyte cell lines comprising a recombinant immune receptor with defined antigen specificity |
| 01/08/2004 | WO2002068650B1 Modified and stabilized gdf propeptides and uses thereof |
| 01/08/2004 | WO2002066622A3 Method of generating diversity into lipolytic enzymes and lipolytic enzyme genes |
| 01/08/2004 | WO2002066053A3 Method of treating or preventing disease characterized by cryptococcus neoformans infection |
| 01/08/2004 | WO2002059310A3 Polynucleotides encoding cellular transporters and methods of use thereof |
| 01/08/2004 | WO2002053596A3 Antibodies to insulin-like growth factor i receptor |
| 01/08/2004 | WO2002046458A3 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 01/08/2004 | WO2002036782A3 Novel glyphosate n-acetyltransferase (gat) genes |
| 01/08/2004 | WO2002036751A3 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 01/08/2004 | WO2000052135A3 Engineering intracellular sialylation pathways |
| 01/08/2004 | US20040006792 Soybean seeds exhibiting oil composition which comprises varying concentrations of oleic acid, linoleic acid, linolenic acid and saturated fatty acids; vegetable oils |
| 01/08/2004 | US20040006784 Methods and compositions for producing plants and microorganisms that express feedback insensitive threonine dehydratase/deaminase |
| 01/08/2004 | US20040006782 Non-human mammal mutant for expression of the alpha6 subunit of the nicotinic acetylcholine receptor, and use for screening substances that can interact with said receptor |
| 01/08/2004 | US20040006780 VEGF-modulated genes and methods employing them |
| 01/08/2004 | US20040006779 Antibodies against gene products related to werner's syndrome |